| URL | https://www.manufacturingdive.com/news/samsung-bio |
| Source | Manufacturing Dive |
| Date Published | 09/15/2025 |
| Author Name | Nathan Owens |
| Company/Division name | Samsung Biologics |
| Parent company | Samsung Biologics |
| Type of work | Manufacturing |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2025 |
| Capital investment ($): | 1,300 |
| Country(ies) from which reshored: | Korea, South |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | Biopharmaceuticals |
| What non-domestic negative factors made offshoring less attractive? | Tariffs, Total cost |